Pattern of Osteosarcoma Among Adolescents and Young Adults in Bihar: A Retrospective Observational Study.
DOI:
https://doi.org/10.51168/sjhrafrica.v7i2.2740Keywords:
Osteosarcoma, Adolescents, Young Adults, Bihar, Bone Tumors, Retrospective StudyAbstract
BackgroundOsteosarcoma is the most common primary malignant bone tumor among adolescents and young adults (AYAs) and is characterized by aggressive local growth and early metastasis. Regional data regarding osteosarcoma patterns in Bihar are limited.
Aim
To analyze the demographic, clinical, radiological, and histopathological patterns of osteosarcoma among AYA patients presenting to a tertiary care hospital in Bihar.
Methods
A retrospective observational study was conducted between January 2024 and June 2025 at a tertiary care hospital in Bihar. Medical records of 40 histopathologically confirmed osteosarcoma patients aged 10–39 years were reviewed. Demographic and clinicopathological variables, including age, sex, tumor location, histological subtype, stage at presentation, and metastatic status, were analyzed using SPSS version 26.0. Chi-square test was used, and p<0.05 was considered statistically significant.
Results
Among 40 patients, 26 (65.0%) were males, and 14 (35.0%) were females. The mean age was 19.8±6.4 years. The distal femur (45.0%) was the most common tumor site, followed by the proximal tibia (30.0%). Osteoblastic osteosarcoma was the predominant histological subtype (60.0%). Metastatic disease at diagnosis was observed in 27.5% of patients. Delayed presentation (>6 months) was significantly associated with metastatic disease (p=0.018).
Conclusion
Osteosarcoma predominantly affected adolescent males and frequently involved bones around the knee joint. Delayed presentation contributed significantly to advanced disease.
Recommendation
Early recognition of persistent bone pain and strengthening referral pathways are recommended to facilitate timely diagnosis and improve outcomes.
References
Bhagat P, Kumar R. Incidence and Spectrum of Childhood Tumors : A Three-Year Hospital-Based Registry Review from a Tertiary Center in Patna. IndJ MedPaediatr Oncol. 2026;March:1-8.
Mittal A, Pushpam D, Ganguly S, Sampath V, Shah K, Khan A. Controversies and Challenges in the Management of Osteosarcoma - an Indian Perspective. Indian J Surg Oncol [Internet]. 2022;13(4):939-55. Available from: https://doi.org/10.1007/s13193-021-01486-3 https://doi.org/10.1007/s13193-021-01486-3
Guillon MAM, Mary PMJ, Brugière L, Marec-bérard P, Pacquement HD, Schmitt C, et al. Clinical characteristics and prognosis of osteosarcoma in young children : a retrospective series of 15 cases. BMC Cancer [Internet]. 2011;11(407):1-7. Available from: http://www.biomedcentral.com/1471-2407/11/407 https://doi.org/10.1186/1471-2407-11-407
Lee JA, Lim J, Jin HY, Park M, Park HJ, Park JW, et al. Osteosarcoma in Adolescents and Young Adults. Cells. 2021;10(2684):1-9. https://doi.org/10.3390/cells10102684
Bal K Mishra AK. Transforming sarcoma treatment : The role of genomic profiling and immunotherapy. Cancer Res Stat Treat. 2025;8(3):4-6. https://doi.org/10.4103/crst.crst_44_25
Ivan A, Cojocaru E, Sirbu PD, Ros D, Namat A. Clinical and Pathological Profile of Children and Adolescents with Osteosarcoma. Diagnostics. 2025;15(266):1-16. https://doi.org/10.3390/diagnostics15030266
Jyoti Bajpai LS, Rath S, Arun Chandrasekharan GP et al. Ten-year follow-up of outcomes, patterns of care, and psychosocial burden in adolescent and young adult patients with bone sarcomas from a large cohort in a low ‐ and middle ‐ income country. Cancer. 2025;e35547(August):1-14.
https://doi.org/10.1002/cncr.35547
Goyal P, Joga S, Tripathi R, Jain A, Sharma M, Goel V, et al. Real World Experience with Osteosarcoma from a Tertiary Cancer Centre in India. J Cancer Sci Clin Ther. 2023;7(2):93-9. https://doi.org/10.26502/jcsct.5079198
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Rahul Anshuman, Surya Prakash, Saurabh Kumar

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
















